Maina Bhaman is a Partner at Sofinnova Partners in London, where she joined in 2018 after serving as director. See sector focus and contact routes.
Maina Bhaman is a Partner at Sofinnova Partners in London, where she joined in 2018 after serving as director of healthcare investment at Touchstone Innovations and working in R&D for biotech firms like Celltech and Oxford GlycoSciences. Her investment focus centers on biotechnology and medical devices, with activity spanning seed to Series A stages across the UK and Europe. While specific check sizes and lead/follow behavior are not publicly detailed, she has invested in companies such as Myricx Bio (Series A) and DISCO Pharmaceuticals (Seed). Her current portfolio includes Sitryx Therapeutics, Cincor, and Enyo Pharma, reflecting her commitment to life sciences innovation. Bhaman holds a B.S. from the University of Texas at Austin and an MBA from Imperial Business School, grounding her venture approach in both scientific and business expertise. No distinctive public writing or unique point of view has been documented in available sources.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in London.
Investors like Maina Bhaman · Full investor directory · Investor access · Company funding database